Impact of Beta-Blockers on Pneumonia, Mortality and Functional Outcomes of Patients with Intracerebral Hemorrhage-A Retrospective Multicenter Study

Bin Gao,1– 3 Anxin Wang,2,4,5 Xiaoli Zhang,2 Jia Zhang,1– 3 Yi Ju,1 Xingquan Zhao,1– 3,6 Wenjuan Wang1– 3 1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2China National Clinical Research Center for Neurological Diseases, Beijing,...

Full description

Saved in:
Bibliographic Details
Main Authors: Gao B, Wang A, Zhang X, Zhang J, Ju Y, Zhao X, Wang W
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/impact-of-beta-blockers-on-pneumonia-mortality-and-functional-outcomes-peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850102283580211200
author Gao B
Wang A
Zhang X
Zhang J
Ju Y
Zhao X
Wang W
author_facet Gao B
Wang A
Zhang X
Zhang J
Ju Y
Zhao X
Wang W
author_sort Gao B
collection DOAJ
description Bin Gao,1– 3 Anxin Wang,2,4,5 Xiaoli Zhang,2 Jia Zhang,1– 3 Yi Ju,1 Xingquan Zhao,1– 3,6 Wenjuan Wang1– 3 1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2China National Clinical Research Center for Neurological Diseases, Beijing, People’s Republic of China; 3Center of Stroke, Beijing Institute for Brain Disorders, Beijing, People’s Republic of China; 4Department of Epidemiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 5Department of Clinical Epidemiology and Clinical Trial, Capital Medical University, Beijing, People’s Republic of China; 6Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, People’s Republic of ChinaCorrespondence: Xingquan Zhao, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 119. Fanyang Road, Fengtai District, Beijing, 100070, People’s Republic of China, Tel +86-135-0103-1486, Email zxq@vip.163.com Wenjuan Wang, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 119. Fanyang Road, Fengtai District, Beijing, 100070, People’s Republic of China, Tel +86-132-6971-0690, Email tong_ttyy@163.comPurpose: Given the current lack of research on the impact of beta-blockers (BB) on clinical outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to evaluate the effect of BB on pneumonia, functional outcomes, and mortality in adult patients with primary ICH.Patients and Methods: This was a retrospective study of a registry cohort of patients with ICH from 13 stroke centers in Beijing, China. Patients aged 18 years or older with first-time primary ICH admitted within 72 h after onset were included. Main exclusion criteria including previous ICH, previous mRS≥ 3, primary intraventricular hemorrhage, missing of baseline data or lost of follow-up. BB group was defined as any use of beta-blockers pre-existing or initiated after onset of ICH, those without any use of beta-blockers were defined as non-BB group. The clinical outcomes were in-hospital pneumonia, mortality and functional outcome (favorable outcome defined as a modified Rankin Score of 0– 3) at 90 d.Results: The study included 947 patients (657 males [69.38%]; mean [standard deviation] age, 57.67 [13.68] years). Two hundred and thirty of 809 patients (28.43%) in the non-BB group and 64 of 138 patients in the BB group were diagnosed with pneumonia (46.38%). Multivariate analysis confirmed that patients in the BB group were likely to have an increased risk of pneumonia after adjusting for confounders (odds ratio [OR], 1.806; 95% confidence interval [CI]:1.139– 2.862; P=0.0119). No statistical difference was observed in the proportion of favorable outcome (P=0.9289) or mortality (P=0.2120) at 90 d between the two groups.Conclusion: The results of this cohort study suggest that any use of BB is associated with an increased risk of pneumonia post-ICH. Randomized clinical trials are needed to evaluate the effects of non-selective BB on the prevention of pneumonia post-ICH.Keywords: beta-blockers, intracerebral hemorrhage, pneumonia, outcome, mortality
format Article
id doaj-art-34762c33bfdb49afac78a2c18be8164a
institution DOAJ
issn 1178-7031
language English
publishDate 2025-07-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj-art-34762c33bfdb49afac78a2c18be8164a2025-08-20T02:39:48ZengDove Medical PressJournal of Inflammation Research1178-70312025-07-01Volume 18Issue 193559364104889Impact of Beta-Blockers on Pneumonia, Mortality and Functional Outcomes of Patients with Intracerebral Hemorrhage-A Retrospective Multicenter StudyGao B0Wang A1Zhang XZhang J2Ju YZhao X3Wang WNeurologyDepartment of EpidemiologyneurologyneurologyBin Gao,1– 3 Anxin Wang,2,4,5 Xiaoli Zhang,2 Jia Zhang,1– 3 Yi Ju,1 Xingquan Zhao,1– 3,6 Wenjuan Wang1– 3 1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2China National Clinical Research Center for Neurological Diseases, Beijing, People’s Republic of China; 3Center of Stroke, Beijing Institute for Brain Disorders, Beijing, People’s Republic of China; 4Department of Epidemiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 5Department of Clinical Epidemiology and Clinical Trial, Capital Medical University, Beijing, People’s Republic of China; 6Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, People’s Republic of ChinaCorrespondence: Xingquan Zhao, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 119. Fanyang Road, Fengtai District, Beijing, 100070, People’s Republic of China, Tel +86-135-0103-1486, Email zxq@vip.163.com Wenjuan Wang, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 119. Fanyang Road, Fengtai District, Beijing, 100070, People’s Republic of China, Tel +86-132-6971-0690, Email tong_ttyy@163.comPurpose: Given the current lack of research on the impact of beta-blockers (BB) on clinical outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to evaluate the effect of BB on pneumonia, functional outcomes, and mortality in adult patients with primary ICH.Patients and Methods: This was a retrospective study of a registry cohort of patients with ICH from 13 stroke centers in Beijing, China. Patients aged 18 years or older with first-time primary ICH admitted within 72 h after onset were included. Main exclusion criteria including previous ICH, previous mRS≥ 3, primary intraventricular hemorrhage, missing of baseline data or lost of follow-up. BB group was defined as any use of beta-blockers pre-existing or initiated after onset of ICH, those without any use of beta-blockers were defined as non-BB group. The clinical outcomes were in-hospital pneumonia, mortality and functional outcome (favorable outcome defined as a modified Rankin Score of 0– 3) at 90 d.Results: The study included 947 patients (657 males [69.38%]; mean [standard deviation] age, 57.67 [13.68] years). Two hundred and thirty of 809 patients (28.43%) in the non-BB group and 64 of 138 patients in the BB group were diagnosed with pneumonia (46.38%). Multivariate analysis confirmed that patients in the BB group were likely to have an increased risk of pneumonia after adjusting for confounders (odds ratio [OR], 1.806; 95% confidence interval [CI]:1.139– 2.862; P=0.0119). No statistical difference was observed in the proportion of favorable outcome (P=0.9289) or mortality (P=0.2120) at 90 d between the two groups.Conclusion: The results of this cohort study suggest that any use of BB is associated with an increased risk of pneumonia post-ICH. Randomized clinical trials are needed to evaluate the effects of non-selective BB on the prevention of pneumonia post-ICH.Keywords: beta-blockers, intracerebral hemorrhage, pneumonia, outcome, mortalityhttps://www.dovepress.com/impact-of-beta-blockers-on-pneumonia-mortality-and-functional-outcomes-peer-reviewed-fulltext-article-JIRbeta-blockersintracerebral hemorrhagepneumoniaoutcomemortality
spellingShingle Gao B
Wang A
Zhang X
Zhang J
Ju Y
Zhao X
Wang W
Impact of Beta-Blockers on Pneumonia, Mortality and Functional Outcomes of Patients with Intracerebral Hemorrhage-A Retrospective Multicenter Study
Journal of Inflammation Research
beta-blockers
intracerebral hemorrhage
pneumonia
outcome
mortality
title Impact of Beta-Blockers on Pneumonia, Mortality and Functional Outcomes of Patients with Intracerebral Hemorrhage-A Retrospective Multicenter Study
title_full Impact of Beta-Blockers on Pneumonia, Mortality and Functional Outcomes of Patients with Intracerebral Hemorrhage-A Retrospective Multicenter Study
title_fullStr Impact of Beta-Blockers on Pneumonia, Mortality and Functional Outcomes of Patients with Intracerebral Hemorrhage-A Retrospective Multicenter Study
title_full_unstemmed Impact of Beta-Blockers on Pneumonia, Mortality and Functional Outcomes of Patients with Intracerebral Hemorrhage-A Retrospective Multicenter Study
title_short Impact of Beta-Blockers on Pneumonia, Mortality and Functional Outcomes of Patients with Intracerebral Hemorrhage-A Retrospective Multicenter Study
title_sort impact of beta blockers on pneumonia mortality and functional outcomes of patients with intracerebral hemorrhage a retrospective multicenter study
topic beta-blockers
intracerebral hemorrhage
pneumonia
outcome
mortality
url https://www.dovepress.com/impact-of-beta-blockers-on-pneumonia-mortality-and-functional-outcomes-peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT gaob impactofbetablockersonpneumoniamortalityandfunctionaloutcomesofpatientswithintracerebralhemorrhagearetrospectivemulticenterstudy
AT wanga impactofbetablockersonpneumoniamortalityandfunctionaloutcomesofpatientswithintracerebralhemorrhagearetrospectivemulticenterstudy
AT zhangx impactofbetablockersonpneumoniamortalityandfunctionaloutcomesofpatientswithintracerebralhemorrhagearetrospectivemulticenterstudy
AT zhangj impactofbetablockersonpneumoniamortalityandfunctionaloutcomesofpatientswithintracerebralhemorrhagearetrospectivemulticenterstudy
AT juy impactofbetablockersonpneumoniamortalityandfunctionaloutcomesofpatientswithintracerebralhemorrhagearetrospectivemulticenterstudy
AT zhaox impactofbetablockersonpneumoniamortalityandfunctionaloutcomesofpatientswithintracerebralhemorrhagearetrospectivemulticenterstudy
AT wangw impactofbetablockersonpneumoniamortalityandfunctionaloutcomesofpatientswithintracerebralhemorrhagearetrospectivemulticenterstudy